Package 43742-2062-1

Brand: vir combination

Generic: influenzinum (2022-2023), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode
NDC Package

Package Facts

Identity

Package NDC 43742-2062-1
Digits Only 4374220621
Product NDC 43742-2062
Product ID 43742-2062_c8718467-946b-45bb-aac9-079ac57593c3
Description

30 mL in 1 BOTTLE, DROPPER (43742-2062-1)

Marketing

Marketing Status
Discontinued 2028-11-17
Brand vir combination
Generic influenzinum (2022-2023), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode
Sample Package No

Linked Drug Pages (1)

Vir Combination ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c8718467-946b-45bb-aac9-079ac57593c3", "openfda": {"unii": ["77H9EM77P7", "TM54L796SN", "FKD3DUK39I", "22G38P19RL", "74J6DNH49U", "2A26YW7PNX", "7COI029E6K", "4IX4VP35CR", "P483J7GX6D", "34C49NV47P", "TBV2PPG6EF", "H2198F8ZNA"], "spl_set_id": ["d9bc9821-6879-41c7-8f4d-63581001797c"], "manufacturer_name": ["Deseret Biologicals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 BOTTLE, DROPPER (43742-2062-1)", "package_ndc": "43742-2062-1", "marketing_end_date": "20281117", "marketing_start_date": "20221205"}], "brand_name": "Vir Combination", "product_id": "43742-2062_c8718467-946b-45bb-aac9-079ac57593c3", "dosage_form": "LIQUID", "pharm_class": ["Actively Acquired Immunity [PE]", "Actively Acquired Immunity [PE]", "Live Human Adenovirus Type 4 Vaccine [EPC]", "Live Human Adenovirus Type 7 Vaccine [EPC]", "Vaccines", "Adenovirus [Chemical/Ingredient]", "Vaccines", "Adenovirus [Chemical/Ingredient]", "Vaccines", "Live", "Unattenuated [Chemical/Ingredient]", "Vaccines", "Live", "Unattenuated [Chemical/Ingredient]"], "product_ndc": "43742-2062", "generic_name": "Influenzinum (2022-2023), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode", "labeler_name": "Deseret Biologicals, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Vir Combination", "active_ingredients": [{"name": "HEPATITIS B VIRUS", "strength": "33 [hp_X]/mL"}, {"name": "HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN", "strength": "12 [hp_C]/mL"}, {"name": "HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN", "strength": "12 [hp_C]/mL"}, {"name": "HUMAN HERPESVIRUS 1", "strength": "15 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 2", "strength": "15 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 4", "strength": "16 [hp_C]/mL"}, {"name": "HUMAN HERPESVIRUS 5", "strength": "15 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 6", "strength": "15 [hp_X]/mL"}, {"name": "INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}, {"name": "INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)", "strength": "12 [hp_X]/mL"}], "marketing_category": "UNAPPROVED HOMEOPATHIC", "marketing_end_date": "20281117", "marketing_start_date": "20221205"}